ArticleMedical immunology (London, England)2004
The quantal theory of how the immune system discriminates between "self and non-self"
Article in Medical immunology (London, England), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 33 citations in OpenAlex.
- Integrated Symbiotic Pleiotropy: Long Non-Coding RNAs and Disordered Proteins Interweaving the Functional Layers of the Eukaryotic Cell.International journal of molecular sciences · 2026Review
- Study on the risk identification of abnormal gas outbursts based on the mechanism of biological immunity.Scientific reports · 2025Article
- Signaling and Function of Interleukin-2 in T Lymphocytes.Annual review of immunology · 2018Review
- Murine liver-resident group 1 innate lymphoid cells regulate optimal priming of anti-viral CD8+ T cells.Journal of leukocyte biology · 2017Article
- Commentary: The Interleukin-2 T Cell System: A New Cell Growth Model.Frontiers in immunology · 2015Article
- Mathematical Models of the Impact of IL2 Modulation Therapies on T Cell Dynamics.Frontiers in immunology · 2013Review
- Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion.Proceedings of the National Academy of Sciences of the United States of America · 2012Article
- Frontiers in immunology - grand challenges.Frontiers in immunology · 2010Article
- Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.Nature genetics · 2009Article
- The T-cell receptor repertoire of regulatory T cells.Immunology · 2008Review
- (123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma.European journal of nuclear medicine and molecular imaging · 2008Article
- Microarray for serotyping of Bartonella species.BMC microbiology · 2007Article
- The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs.Medical immunology (London, England) · 2006Article
- Construction, purification, and characterization of a chimeric TH1 antagonist.BMC biotechnology · 2006Article
- Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor.Proceedings of the National Academy of Sciences of the United States of America · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
In the past 50 years, immunologists have accumulated an amazing amount of information as to how the immune system functions. However, one of the most fundamental aspects of immunity, how the immune system discriminates between self vs. non-self, still remains an enigma. Any attempt to explain this most intriguing and fundamental characteristic must account for this decision at the level of the whole immune system, but as well, at the level of the individual cells making up the immune system. Moreover, it must provide for a molecular explanation as to how and why the cells behave as they do. The "Quantal Theory", proposed herein, is based upon the "Clonal Selection Theory", first proposed by Sir McFarland Burnet in 1955, in which he explained the remarkable specificity as well as diversity of recognition of everything foreign in the environment. The "Quantal Theory" is built upon Burnet's premise that after antigen selection of cell clones, a proliferative expansion of the selected cells ensues. Furthermore, it is derived from experiments which indicate that the proliferation of antigen-selected cell clones is determined by a quantal, "all-or-none", decision promulgated by a critical number of cellular receptors triggered by the T Cell Growth Factor (TCGF), interleukin 2 (IL2). An extraordinary number of experiments reported especially in the past 20 years, and detailed herein, indicate that the T cell Antigen Receptor (TCR) behaves similarly, and also that there are several critical numbers of triggered TCRs that determine different fates of the T cells. Moreover, the fates of the cells appear ultimately to be determined by the TCR triggering of the IL2 and IL2 receptor (IL2R) genes, which are also expressed in a very quantal fashion. The "Quantal Theory" states that the fundamental decisions of the T cell immune system are dependent upon the cells receiving a critical number of triggered TCRs and IL2Rs and that the cells respond in an all-or-none fashion. The "Quantal Theory" accounts fully for the development of T cells in the thymus, and such fundamental cellular fates as both "positive" and "negative" selection, as well as the decision to differentiate into a "Regulatory T cell" (T-Reg). In the periphery, the "Quantal Theory" accounts for the decision to proliferate or not in response to the presence of an antigen, either non-self or self, or to differentiate into a T-Reg. Since the immune system discriminates between self and non-self antigens by the accumulated number of triggered TCRs and IL2Rs, therapeutic manipulation of the determinants of these quantal decisions should permit new approaches to either enhance or dampen antigen-specific immune responses.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.